Indivior Pharmaceuticals (INDV) Change in Receivables (2024 - 2026)

Indivior Pharmaceuticals' Change in Receivables history runs 3 years deep, the most recent figure standing at $20.0 million for Q1 2026.

• In Q1 2026, Change in Receivables rose 281.82% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $28.0 million (up 566.67% YoY), while the FY2025 annual figure was -$3.0 million, down 400.0% from the prior year.
• Change in Receivables was $20.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$6.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $20.0 million in Q1 2026 to a low of -$11.0 million in Q1 2025.
• Historically, Change in Receivables has averaged $2.0 million across 3 years, with a median of -$4.0 million in 2024.
• Biggest YoY gain for Change in Receivables was 300.0% in 2025; the steepest drop was 250.0% in 2025.
• A 3-year view of Change in Receivables shows it stood at $4.0 million in 2024, then plunged by 250.0% to -$6.0 million in 2025, then jumped by 433.33% to $20.0 million in 2026.
• The last three Change in Receivables figures came in at $20.0 million (Q1 2026), -$6.0 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.